MT Newswires Canada Stocks To Watch: Cogecos; Black Diamond; Brookfield Asset Management and Brookfield Corp; Eupraxia

MT Newswires
01 Nov 2024

Cogeco Communications Inc. (CCA.TO) announced its financial results for the fourth quarter ended August 31, 2024 and issued its fiscal 2025 financial guidelines. It reported Q4 adjusted diluted earnings per share of $2.35 versus $2.19 a year earlier. Revenue increased by 0.6% to $747.8 million. The company said it "met or exceeded" all financial guidelines set for fiscal 2024. It increased its quarterly eligible dividend by 8.0% to $0.922 per share.

For its part, Cogeco Inc. (TSX: CGO) reported Q4 adjusted diluted EPS of $2.65 versus $2.12.
Revenue remained stable at $768.7 million. It too "met or exceeded" all financial guidelines set for fiscal 2024; issued fiscal 2025 financial guidelines. It increased the quarterly eligible dividend by 8.0% to $0.922 per share.

Meanwhile, Black Diamond Group Limited (BDI.TO), a provider of space rental and workforce accommodation solutions, reported EPS Basic and Diluted of $0.12, down from $0.22 a year ago. Consolidated rental revenue of $37.9 million decreased a modest 4% as compared to the Comparative Quarter and was up 7% from the second quarter of 2024. But on outlook, the company said it remains "well positioned" for continued growth over the remainder of 2024 and into 2025. The positive outlook for the business is driven in-part by over $163.8 million of contracted future rental revenue, up 27% from the end of the comparative quarter. It added the "meaningful" growth in future contracted rental revenues has been driven by the company's disciplined organic growth initiatives this year with $94.5 million of gross capital expenditures for the year, as well as renewals of existing contracts. Given continued strength across the rental platform, subsequent to the end of the quarter, the company announced a 17% increase to its quarterly dividend from $0.03 to $0.035 per quarter. The fourth quarter dividend of $0.035 is payable on or about January 15, 2025 to shareholders of record on December 31, 2024.

Elsewhere, Brookfield Asset Management Ltd. (NYSE and TSX BAM) and Brookfield Corporation announced steps towards "enhancing BAM's corporate structure and positioning BAM for broader equity index inclusion, particularly those in the United States". As part of this effort, BAM has now changed its head office to New York. In addition, BAM and BN have entered into an agreement whereby BAM would own and reflect 100% of the asset management business, and BN's current 73% interest in the asset management business would be held directly through ownership of approximately 73% of the publicly traded shares of BAM. A statement noted the arrangement will not result in any changes to the operations or strategic plans of BAM or BN and will have no effect on the tax treatment of their respective dividends. BAM expects to hold a special meeting for shareholders to consider and vote on the arrangement on December 20, 2024. If approved then, the arrangement is expected to close in early 2025, subject to court approval and other customary closing conditions, including NYSE and TSX listing approvals.

And Eupraxia Pharmaceuticals Inc. (EPRX.TO and NASDAQ: EPRX), a clinical-stage biotechnology company leveraging its proprietary DiffuSphere technology to optimize drug delivery for applications with significant unmet need, completed a non-brokered private placement of 8,905,638 Series 1 Preferred shares of the company, at a price of C$5.00 per Preferred Share for aggregate gross proceeds of C$44,528,190, by way of a non-brokered private placement. The company intends to use the net proceeds towards the funding of clinical trials for EP104GI, initiating research programs for new candidates and general corporate and working capital purposes of the company and its affiliates








Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10